4//SEC Filing
FOSTER JAMES C 4
Accession 0001127602-24-021581
CIK 0001100682other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:04 PM ET
Size
10.1 KB
Accession
0001127602-24-021581
Insider Transaction Report
Form 4
FOSTER JAMES C
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-08-01$250.00/sh−25,000$6,250,000→ 188,251 total
Holdings
- 9,793(indirect: 2023 GRAT)
Common Stock
- 2,250(indirect: By Trust)
Common Stock
- 7,580(indirect: 2022 GRAT)
Common Stock
- 20,000(indirect: 2024 GRAT)
Common Stock
- 750(indirect: By Trust)
Common Stock
- 10,000(indirect: By Spouse)
Common Stock
- 230(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 26, 2024.
- [F2]On 6/5/2024, 10,207 shares were transferred from the 2023 GRAT account to Direct holdings.
- [F3]On 6/6/2024, 20,000 shares were transferred from Direct holdings to 2024 GRAT account.
- [F4]Reflects a reduction by 110 shares that were inadvertently reported as being held by the Reporting Person.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001141722
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:04 PM ET
- Size
- 10.1 KB